(Q43944776)

28 November 2017

Development of an economic model to assess the cost effectiveness of asthma management strategies (English)

1 reference

cost-effectiveness analysis

28 November 2017

0 references

1 reference

Martin J Price

1

1 reference

PubMed ID

11929348

28 November 2017

Andrew H Briggs

series ordinal

2

1 reference

28 November 2017

1 January 2002

1 reference

28 November 2017

1 reference

28 November 2017

20

1 reference

28 November 2017

3

1 reference

28 November 2017

183-194

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200220030-00004

28 November 2017

0 references

cites work

An economic evaluation of asthma in the United States

1 reference

12 December 2020

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach

1 reference

12 December 2020

Is overall asthma control being achieved? A hypothesis-generating study

1 reference

12 December 2020

Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients

1 reference

12 December 2020

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

12 December 2020

Probabilistic sensitivity analysis methods for general decision models

1 reference

12 December 2020

Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis

1 reference

12 December 2020

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

An introduction to Markov modelling for economic evaluation

1 reference

12 December 2020

10.2165/00019053-200220030-00004

Identifiers

DOI

1 reference

PubMed ID

11929348

Dimensions Publication ID

28 November 2017

0 references

1 reference

PubMed ID

11929348